Cryolife INC
SEC CIK 784199 · CRY · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Semedo Anthony B. | Director | filed 2021–2026 |
| Ackerman Thomas F | Director | filed 2006–2026 |
| Bullock James | Director | filed 2016–2026 |
| Bevevino Daniel J | Director | filed 2006–2026 |
| Burbank Jeffrey H | Director | filed 2018–2026 |
| Salveson Jon W | Director | filed 2012–2026 |
| Borgstrom Marna P | Director | filed 2018–2026 |
| Hoff Elizabeth A | Director | filed 2022–2026 |
| Morgan Harvey | Director | filed 2008–2021 |
| Mccall Ronald D | Director | filed 2006–2021 |
| Ronald C Elkins | Director | filed 2006–2018 |
| Benson James | Director | filed 2006–2017 |
| Anderson Steven G | Director · President, CEO and Chairman | filed 2006–2015 |
| Cook John M | Director | filed 2006–2009 |
| Lacy Virginia C | Director | filed 2006–2007 |
| VAN Dyne Bruce J MD | Director | filed 2006–2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Green Andrew M | VP Regulatory | filed 2021–2026 |
| Horton Amy | VP, Chief Accounting Officer | filed 2006–2026 |
| Mackin James P | President & CEO | filed 2014–2026 |
| Berry Lance A | Executive VP, CFO | filed 2023–2026 |
| Holloway Jean F | VP, General Counsel | filed 2015–2026 |
| Davis John E | Senior VP, Global Sales | filed 2015–2026 |
| Stanton Marshall S. | SVP, Clinical & MD Affair | filed 2021–2026 |
| Getz Matthew A | VP, Human Resources | filed 2019–2024 |
| Maney Rochelle L. | VP, Quality | filed 2021–2024 |
| Tyrs Florian | VP, Global Operations | filed 2023–2024 |
| Thomson Robert C | VP Research & Development | filed 2023–2024 |
| Maier Dennis B | Vice President, Operations | filed 2018–2023 |
| LEE David Ashley | VP, CFO and Treasurer | filed 2006–2023 |
| Barthold Franz Peter | VP, Research & Development | filed 2020–2022 |
| Capps Scott B | VP-Clinical Research | filed 2007–2021 |
| Simpson Michael S | SVP, Regulatory Affairs and QA | filed 2018–2021 |
| Bogenschuetz Thomas J | VP, EMEA & General Manager | filed 2018–2020 |
| Saurini Sherry M | VP, Quality | filed 2016–2019 |
| Mcdermid James M | SVP, CHRO | filed 2016–2019 |
| Matthews William Robert | Senior VP, Operations, Quality | filed 2015–2018 |
| Gale David C | VP-Research and Development | filed 2012–2017 |
| Fronk David | VP, Regulatory Affairs | filed 2006–2015 |
| Anderson Bruce G. | VP, US Sales and Marketing | filed 2012–2015 |
| Lang David P. | VP, Int'l Sales & Marketing | filed 2012–2015 |
| Burris Jeffrey W | Vice President & Gen. Counsel | filed 2010–2014 |
| Seery Gerald B | Sr. VP, Sales and Marketing | filed 2006–2012 |
| Heacox Albert E | Sr. VP Research and Devl | filed 2006–2012 |
| Theodore Philip A | VP, General Counsel | filed 2007–2007 |
| Ashmore Sidney B | Vice President of Marketing | filed 2006–2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.